BMND7
MCID: BNM021
MIFTS: 13

Bone Mineral Density Quantitative Trait Locus 7 (BMND7)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Bone Mineral Density Quantitative Trait Locus 7

MalaCards integrated aliases for Bone Mineral Density Quantitative Trait Locus 7:

Name: Bone Mineral Density Quantitative Trait Locus 7 56
Bmnd7 56

Classifications:



External Ids:

OMIM 56 611738

Summaries for Bone Mineral Density Quantitative Trait Locus 7

MalaCards based summary : Bone Mineral Density Quantitative Trait Locus 7, also known as bmnd7, is related to osteoporosis. An important gene associated with Bone Mineral Density Quantitative Trait Locus 7 is BMND7 (Bone Mineral Density Quantiative Trait Locus 7). The drugs Reboxetine and Citalopram have been mentioned in the context of this disorder. Affiliated tissues include bone.

More information from OMIM: 611738

Related Diseases for Bone Mineral Density Quantitative Trait Locus 7

Symptoms & Phenotypes for Bone Mineral Density Quantitative Trait Locus 7

Clinical features from OMIM:

611738

Drugs & Therapeutics for Bone Mineral Density Quantitative Trait Locus 7

Drugs for Bone Mineral Density Quantitative Trait Locus 7 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Reboxetine Approved, Experimental Phase 3 98769-81-4, 71620-89-8 123628 65856
2
Citalopram Approved Phase 3 59729-33-8 2771
3
Sertraline Approved Phase 3 79617-96-2 68617
4
Norepinephrine Approved Phase 3 51-41-2 439260
5 Antidepressive Agents Phase 3
6 Adrenergic Agents Phase 3
7 Psychotropic Drugs Phase 3
8 Serotonin Uptake Inhibitors Phase 3
9 Venlafaxine Hydrochloride Phase 3
10 Serotonin and Noradrenaline Reuptake Inhibitors Phase 3
11 Neurotransmitter Agents Phase 3
12
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 International Committee of Medical Journal Editors Completed NCT02179268 Phase 3 sertraline;citalopram;venlafaxine;reboxetine

Search NIH Clinical Center for Bone Mineral Density Quantitative Trait Locus 7

Genetic Tests for Bone Mineral Density Quantitative Trait Locus 7

Anatomical Context for Bone Mineral Density Quantitative Trait Locus 7

MalaCards organs/tissues related to Bone Mineral Density Quantitative Trait Locus 7:

40
Bone

Publications for Bone Mineral Density Quantitative Trait Locus 7

Articles related to Bone Mineral Density Quantitative Trait Locus 7:

# Title Authors PMID Year
1
Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. 56
20096396 2010
2
Linkage of osteoporosis to chromosome 20p12 and association to BMP2. 56
14691541 2003

Variations for Bone Mineral Density Quantitative Trait Locus 7

Expression for Bone Mineral Density Quantitative Trait Locus 7

Search GEO for disease gene expression data for Bone Mineral Density Quantitative Trait Locus 7.

Pathways for Bone Mineral Density Quantitative Trait Locus 7

GO Terms for Bone Mineral Density Quantitative Trait Locus 7

Sources for Bone Mineral Density Quantitative Trait Locus 7

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....